# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $87 to $89.
Barclays analyst Matt Miksic initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Equal-Weight rating and announce...
Citigroup analyst Joanne Wuensch downgrades GE HealthCare Techs (NASDAQ:GEHC) from Buy to Neutral and lowers the price targe...
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...
https://www.bloomberg.com/news/articles/2025-09-18/ge-healthcare-is-said-to-explore-selling-stake-in-china-business?srnd=homepa...
The anticipated acquisition aligns with GE HealthCare's precision care strategy with the goal of strengthening the company&...